Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Nordnet Pensionsförsäkring | 13,31 | 13,31 | 2022-03-31 |
| Avanza Pension | 12,50 | 12,50 | 2022-03-31 |
| Anders Ericsson | 6,18 | 6,18 | 2022-05-17 |
| Jan-Willem De Gier | 5,16 | 5,16 | 2022-03-31 |
| Joen Luirink | 5,04 | 5,04 | 2022-03-31 |
| John Moll | 4,90 | 4,90 | 2021-02-08 |
| Magnus Linderoth | 4,49 | 4,49 | 2022-03-31 |
| Johan Källstrand | 3,50 | 3,50 | 2022-03-31 |
| Anders Wall Stiftelser | 2,77 | 2,77 | 2022-03-31 |
| Mårten Hellberg | 2,28 | 2,28 | 2021-02-08 |
2022-08-16 Delårsrapport 2022-Q2
2022-11-10 Delårsrapport 2022-Q3
2023-02-23 Bokslutskommuniké 2022